198 related articles for article (PubMed ID: 16827586)
1. Molecular interactions of dendrimers with amyloid peptides: pH dependence.
Klajnert B; Cladera J; Bryszewska M
Biomacromolecules; 2006 Jul; 7(7):2186-91. PubMed ID: 16827586
[TBL] [Abstract][Full Text] [Related]
2. Influence of dendrimer's structure on its activity against amyloid fibril formation.
Klajnert B; Cortijo-Arellano M; Cladera J; Bryszewska M
Biochem Biophys Res Commun; 2006 Jun; 345(1):21-8. PubMed ID: 16674918
[TBL] [Abstract][Full Text] [Related]
3. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208.
Klajnert B; Cortijo-Arellano M; Cladera J; Majoral JP; Caminade AM; Bryszewska M
Biochem Biophys Res Commun; 2007 Dec; 364(1):20-5. PubMed ID: 17927954
[TBL] [Abstract][Full Text] [Related]
4. Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils.
LeVine H
Arch Biochem Biophys; 1997 Jun; 342(2):306-16. PubMed ID: 9186492
[TBL] [Abstract][Full Text] [Related]
5. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
6. Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation.
Chafekar SM; Malda H; Merkx M; Meijer EW; Viertl D; Lashuel HA; Baas F; Scheper W
Chembiochem; 2007 Oct; 8(15):1857-64. PubMed ID: 17763487
[TBL] [Abstract][Full Text] [Related]
7. EPR study of the interactions between dendrimers and peptides involved in Alzheimer's and prion diseases.
Klajnert B; Cangiotti M; Calici S; Majoral JP; Caminade AM; Cladera J; Bryszewska M; Ottaviani MF
Macromol Biosci; 2007 Aug; 7(8):1065-74. PubMed ID: 17654761
[TBL] [Abstract][Full Text] [Related]
8. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases.
Klajnert B; Cortijo-Arellano M; Bryszewska M; Cladera J
Biochem Biophys Res Commun; 2006 Jan; 339(2):577-82. PubMed ID: 16310169
[TBL] [Abstract][Full Text] [Related]
9. Probing the amyloid-beta(1-40) fibril environment with substituted tryptophan residues.
Touchette JC; Williams LL; Ajit D; Gallazzi F; Nichols MR
Arch Biochem Biophys; 2010 Feb; 494(2):192-7. PubMed ID: 19995549
[TBL] [Abstract][Full Text] [Related]
10. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
Benseny-Cases N; Cócera M; Cladera J
Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
[TBL] [Abstract][Full Text] [Related]
11. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.
Alvarez A; Opazo C; Alarcón R; Garrido J; Inestrosa NC
J Mol Biol; 1997 Sep; 272(3):348-61. PubMed ID: 9325095
[TBL] [Abstract][Full Text] [Related]
13. Amyloidogenic properties of the prion protein fragment PrP(185-208): comparison with Alzheimer's peptide Abeta(1-28), influence of heparin and cell toxicity.
Cortijo-Arellano M; Ponce J; Durany N; Cladera J
Biochem Biophys Res Commun; 2008 Apr; 368(2):238-42. PubMed ID: 18206983
[TBL] [Abstract][Full Text] [Related]
14. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.
LeVine H
Protein Sci; 1993 Mar; 2(3):404-10. PubMed ID: 8453378
[TBL] [Abstract][Full Text] [Related]
15. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
16. Charge substitution shows that repulsive electrostatic interactions impede the oligomerization of Alzheimer amyloid peptides.
Guo M; Gorman PM; Rico M; Chakrabartty A; Laurents DV
FEBS Lett; 2005 Jul; 579(17):3574-8. PubMed ID: 15964569
[TBL] [Abstract][Full Text] [Related]
17. Amyloid beta (1-42) folding multiplicity and single-molecule binding behavior studied with STM.
Ma X; Liu L; Mao X; Niu L; Deng K; Wu W; Li Y; Yang Y; Wang C
J Mol Biol; 2009 May; 388(4):894-901. PubMed ID: 19328210
[TBL] [Abstract][Full Text] [Related]
18. Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta.
Wood SJ; Maleeff B; Hart T; Wetzel R
J Mol Biol; 1996 Mar; 256(5):870-7. PubMed ID: 8601838
[TBL] [Abstract][Full Text] [Related]
19. Amphotericin B binds to amyloid fibrils and delays their formation: a therapeutic mechanism?
Hartsel SC; Weiland TR
Biochemistry; 2003 May; 42(20):6228-33. PubMed ID: 12755626
[TBL] [Abstract][Full Text] [Related]
20. Multiple-peptide conjugates for binding beta-amyloid plaques of Alzheimer's disease.
Zhang G; Leibowitz MJ; Sinko PJ; Stein S
Bioconjug Chem; 2003; 14(1):86-92. PubMed ID: 12526697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
